Regeneron Pharma Margins Tighten As Competition Grows, Stock Slides

benzinga.com/25/04/45079889/regeneron-pharmaceuticals-q1-earnings-falls-short-on-expectations-revises-2025-gross-margin-outlook

On Tuesday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported first-quarter adjusted earnings per share of $8.22, down 14% year-over-year, missing the consensus of $8.82.
The company reported sales of $3.03 billion, down 4%, missing the consensus of $3.29 billion.
In the first…

This story appeared on benzinga.com, 2025-04-29 18:52:27.
The Entire Business World on a Single Page. Free to Use →